IPO registrations (S-1, F-1) · Registrants

ARGONAUT TECHNOLOGIES INC

SEC CIK
1112880 · filings on EDGAR ↗
Registration
Form S-1, first filed 2000-04-27, last 2000-07-18; 1 initial registration, 4 amendments
Outcome
Final prospectus filed 2000-07-19
Industry (SIC)
In Vitro & In Vivo Diagnostic Substances 2835
Incorporated in
DE
Business address
220 SAGINAW DRIVE, Redwood City, CA 94063
EIN
94-3216714
EDGAR entity type
operating

Offering terms

Proposed price range
$13.00–$15.00 per share (S-1/A filed 2000-07-18)
Final price
$0.76 per share, below the range (424B4 filed 2000-07-19, an initial public offering)
Shares sold
4,600,000
Gross proceeds
$3,496,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol AGNT
Lead underwriters
UBS (2,090,000 shares)
Syndicate
ING; Cowen (1,045,000); ING Barings LLC (1,045,000); Bear Stearns (70,000); Cantor Fitzgerald (70,000); Morgan Stanley (70,000); RBC Capital Markets (35,000); Gruntal & Co., L.L.C (35,000); Pacific Growth Equities, Inc (35,000); Pennsylvania Merchant Group (35,000); Raymond James (35,000); Wedbush Securities (35,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 7

FiledFormWhat it isName as filedEDGAR
2000-04-27S-1S-1 (registration)ARGONAUT TECHNOLOGIES INC0000891618-00-002375 ↗
2000-05-18S-1/AS-1/A (amendment)ARGONAUT TECHNOLOGIES INC0000891618-00-002969 ↗
2000-06-19S-1/AS-1/A (amendment)ARGONAUT TECHNOLOGIES INC0000891618-00-003422 ↗
2000-07-14S-1/AS-1/A (amendment)ARGONAUT TECHNOLOGIES INC0000891618-00-003861 ↗
2000-07-18S-1/AS-1/A (amendment)ARGONAUT TECHNOLOGIES INC0000891618-00-003926 ↗
2000-07-19S-1MEFS-1MEF (added securities)ARGONAUT TECHNOLOGIES INC0000891618-00-003956 ↗
2000-07-19424B4424B4 (final prospectus)ARGONAUT TECHNOLOGIES INC0000891618-00-003969 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2000-07-18S-1/Aregistration statement$13.00–$15.004,000,000-Nasdaq AGNT4primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 4document ↗
2000-07-19424B4final prospectus$0.764,600,000$3,496,000Nasdaq AGNT13primary document; price line, shares headline, proceeds computed, underwriting table 12, cover names 3document ↗

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationARGONAUT TECHNOLOGIES, INC.CAState business registriesname and state
Trademark ownerArgonaut Technologies, Inc.CATrademarks (USPTO)name and state
Form 5500 plan sponsorARGONAUT TECHNOLOGIES, INC.EIN (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry In Vitro & In Vivo Diagnostic Substances, CA first:

More with this interest.

In other datasets, the same topic (Health) in CA:

Interests: In Vitro & In Vivo Diagnostic Substances · Health